Lindbrook Capital, LLC Genfit S.A. Transaction History

Lindbrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$3.67 - $5.59 $943 - $1,436	-257 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$5.2 - $22.0 $457 - $1,936	88 Added 52.07%	257 $1,000
Q1 2020 Apr 22, 2020	SELL	$10.95 - $20.76 $2,584 - $4,899	-236 Reduced 58.27%	169 $2,000
Q4 2019 Jan 27, 2020	BUY	$13.55 - $20.14 $5,487 - $8,156	405 New	405 $8,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.